Streetbeat News

Regulatory

HCI

HCI Group, Inc. (NYSE:HCI) has filed a universal shelf registration statement on Form S-3 with the United States Securities and Exchange Commission, replacing an expired one. This will provide HCI the flexibility to publicly offer and sell various securities in the future. However, HCI has no immediate plans to offer or sell any securities under the shelf registration statement to the public.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:22 pm

AAPL

MPC

NVDA

QCOM

VLO

The week saw a surge in oil prices due to production cuts by Saudi Arabia and Russia, causing concerns about inflation and higher interest rates. The US economy showed resilience with strong service sector expansion. The US Dollar and Treasury yields rose as investors revised their forecasts regarding the Federal Reserve’s interest rate stance. Tensions escalated in the auto sector with potential strike involving 146,000 members. SEC investigates GameStop CEO for his stock trades. Apple's market value plummeted by nearly $200 billion over two days due to China's intention to forbid public workers from using iPhones. US semiconductor stocks weakened amid concerns over new export restrictions on China. The energy sector excelled, with Marathon Petroleum Corp and Valero Energy among the top-performing S&P 500 stocks for the week.

Portfolio Pulse from Piero Cingari

September 08, 2023 | 8:15 pm

REKR

Rekor Systems Inc has filed for an offering of 2.85 million shares of common stock by the selling stockholder, according to a SEC filing.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:10 pm

VIGL

Vigil Neuroscience Inc. has announced that Phase 1 dosing is expected to commence in October 2023, with no anticipated delays in current clinical development plans. The Investigational New Drug (IND) application for VG-3927 is now open.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:10 pm

VIGL

Vigil Neuroscience (NASDAQ:VIGL) has announced VG-3927 as its lead candidate for the treatment of Alzheimer's Disease. The company's Investigational New Drug (IND) application for VG-3927 has been approved by the FDA, with a partial clinical hold related to maximum exposure limit. Phase 1 clinical trial in healthy volunteers is expected to commence in October 2023. The company will host a virtual R&D event on September 13, 2023, to highlight its small molecule TREM2 agonist program.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:10 pm

LOVE

Lovesac's management and audit committee have concluded that the company's prior financial statements should no longer be relied upon. The company will restate its prior financial statements and amend its annual report on Form 10-K for the fiscal year ended January 29, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:08 pm

LOVE

Lovesac Co has filed a non-timely 10-Q with the U.S. SEC, citing errors in the methodology used to calculate the accrual of last mile freight expenses applicable to financial statements for the fiscal year ended January 29, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:07 pm

ET

The U.S. Army Corps of Engineers has released a draft Environmental Impact Statement on Energy Transfer's Dakota Access Oil Pipeline. The draft evaluates five alternatives for the pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:05 pm

AMZN

CHD

Church & Dwight Co., Inc. (NYSE:CHD) has initiated a voluntary recall of one specific lot of TheraBreath Strawberry Splash for Kids 16oz due to microbial contamination. The product was sold exclusively on Amazon between May 31 and September 02, 2023. The company is coordinating with the U.S. Food & Drug Administration (FDA) and is offering a full refund to consumers who purchased the affected product.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 8:02 pm

BA

RTX

UAL

The U.S. National Transportation Safety Board has cited a failure to inspect engine fan blades in a timely manner as the cause of the February 2021 engine failure in a United Airlines Boeing 777 aircraft.

Portfolio Pulse from Benzinga Newsdesk

September 08, 2023 | 7:58 pm